GE Medical absorbs small CIS firm

Article

GE Medical Systems Information Technologies has purchased SEC, a developer of enterprise-wide clinical information systems. Terms of the deal were not disclosed. SEC's suite of CIS software applies client-server and Internet-based

GE Medical Systems Information Technologies has purchased SEC, a developer of enterprise-wide clinical information systems. Terms of the deal were not disclosed. SEC's suite of CIS software applies client-server and Internet-based architecture to enable efficient point-of-care clinical work processes and provide a single, comprehensive clinical data repository. Vik Kheterpal, formerly president and CEO of SEC, is now general manager of CIS for GE.

In a related development, Sentillion's Vergence Context Management software will be integrated into GE's QS clinical information system for use in perinatal and critical care applications. GE is using Vergence software development tools to enhance QS with the HL7 CCOW standard, which defines the basis for creating a cooperative, multivendor clinical desktop.


© 2000 Miller Freeman Inc.
11/29/00, Issue # 117, page 5.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.